Trending Now
Avenue Therapeutics Inc.’s (NASDAQ: ATXI) IV Tramadol Receives FDA Rejection
Avenue Therapeutics Inc. (NASDAQ: ATXI) has announced the outcome of its US FDA joint meeting of the Anaesthetic and Analgesic Drug Products Advisory Committee...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Zafgen Inc. (NASDAQ:ZFGN) Announces Reverse Merger With Chondrial Therapeutics With New...
Zafgen Inc. (NASDAQ:ZFGN) and Chondrial Therapeutics Inc. have announced the finalization of a reverse merger transaction forming a new public company. The combined biotechnology...
MAKE IT MODERN
LATEST REVIEWS
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posts Revenues Of $62.4 Million In Q2...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) reported a growth of 41% YoY to $62.4 million in Q2 2020. It is on the backdrop of strong patient...
MAKE IT MODERN
PERFORMANCE TRAINING
Abeona Therapeutics Inc (NASDAQ: ABEO) and the FDA have a Successful Type-B Meeting for...
Abeona Therapeutics Inc (NASDAQ: ABEO) is a fully integrated authority in the cell and gene therapy space. It recently announced that it had a fruitful...
Cybersecurity Stocks could be inflation resistant (CRWD,VMW,GTLB,AETN)
There is no doubt that cyber attacks are costing companies millions of dollars every year. This in turn has created a solid...
MCTC Expands into Cannabis Mobile Dispensary Space
MCTC Holdings Inc (OTCMKTS:MCTC), now doing business as Cannabis Global, Inc. (OTCMKTS:MCTC), is interesting on a number of levels.
First off, the company is that...
Why Halberd Corp (OTCMKTS:HALB) Deserves a Look on Diversified Virus Response
If you haven’t heard of Halberd Corp (OTCMKTS:HALB), now is the time to take a first look.
If you’ve...
Humanigen Inc (NASDAQ: HGEN) Announce Publication of Sub Analysis of Phase 3 LIVE-AIR Study...
Humanigen Inc (NASDAQ: HGEN) has announced a peer-reviewed publication of a sub-analysis of Phase 3 LIVE-AIR study of lenzilumab in Thorax. Thorax is the...
MAKE IT MODERN
